PubMed Health⌕ Search

Biomedical subjects

S Chiu

Publications and source records attributed to S Chiu.

68 records · Page 4Linked to original sources
PubMed1978

Deranged diurnal feeding pattern and altered brain serotonin turnover in heroin-dependent rats.

Rats rendered tolerant to and dependent on heroin by administering escalating dosages of heroin from 5 mg/kg-1 to 30 mg/kg-1 s,c, twice daily for 10 days exhibited disrupted diurnal feeding patterns. Daylight food intake was significantly increased, whereas night-time feeding was significantly decreased, as compared with the saline-control group. Growth rate evaluated on the basis of changes in daily body weights was considerably attenuated. The heroin-treated rats showed typical abstinence signs upon naloxone challenge 8 hr after the last heroin challenge. No significant changes were observed in the brain levels of tryptophan, serotonin and 5-hydroxyindoleacetic acid. The formation of newly synthesised 3H-serotonin from 3H-tryptophan was significantly reduced, as evidenced from the decreased specific activity of serotonin. The results obtained in this study indicate that whereas the perturbed diurnal feeding activity cannot be ascribed exclusively to altered central serotonergic mechanism, chronic heroin treatment appears to decrease the rate of serotonin via a negative feedback loop.

Animals↗
PubMedDate not supplied

Mesolimbic and striatal dopamine receptor supersensitivity: prophylactic and reversal effects of L-prolyl-L-leucyl-glycinamide (PLG).

Functional supersensitivity of mesolimbic and striatal dopamine receptors has been suggested to contribute to the pathogenesis of schizophrenia and tardive dyskinesia. Using the rodent model of chronic administration of the neuroleptic haloperidol, we investigated the possible desensitizing effects of a tripeptide structurally unrelated to dopamine agonists, L-prolyl-L-leucyl-glycinamide (PLG) on mesolimbic and striatal dopaminergic receptor supersensitivity. Administration of PLG either prior to or after chronic haloperidol, inhibited the supersensitivity of dopamine receptors. The results have implications for pharmacological intervention in preventing tardive dyskinesia and relapse psychosis of schizophrenia.

Animals↗
PubMedDate not supplied

Down-regulation of haloperidol-induced striatal dopamine receptor supersensitivity by active analogues of L-prolyl-L-leucyl-glycinamide (PLG).

Tardive dyskinesia, a clinical syndrome, is one of the major side effects of protracted treatment with neuroleptics in schizophrenic patients. Functional supersensitivity of striatal dopamine receptors is believed to contribute to the pathogenesis of schizophrenia and tardive dyskinesia. In a rodent model of neuroleptic-induced dopamine receptor supersensitivity, we investigated the efficacy of structurally modified analogues of PLG to down-regulate the striatal dopamine receptor supersensitivity as determined by alterations in [3H]spiroperidol binding to striatal membranes in vitro. The PLG analogue, L-prolyl-L-leucyl-(+)-thiazolidine-2-carboxamide-HCl, when given at the dose of 10 mg/kg IP for 5 days prior to haloperidol (3 mg/kg IP 21 days) significantly prevented the up-regulation of striatal dopamine receptor supersensitivity, thus demonstrating a prophylactic effect. Two other analogues, L-prolyl-L-leucyl-5-aminomethyltetrazole and L-prolyl-L-leucyl-glycine-dimethylamide at a dose of 10 mg/kg IP when given concurrently with haloperidol for 21 days, suppressed the development of dopamine receptor supersensitivity. None of the analogues tested in the post-haloperidol session reversed the haloperidol-induced increase in the density of striatal dopamine receptors. Active PLG analogues hold promise as potential therapeutic agents for the amelioration of tardive dyskinesia.

Animals↗
PubMedDate not supplied

17 beta Estradiol-induced increase in brain dopamine D-2 receptor: antagonism by MIF-1.

Animal behavioral and neurochemical studies implicate dopaminergic systems in the neurological sequelae induced by estrogen. In the present study, we demonstrated for the first time that MIF-1, a neuropeptide unrelated to classical dopamine agonists, when given prior to, concurrently with, and after 17 beta-estradiol, antagonized significantly the estrogen-induced increase in the density of dopamine D-2 receptor both in the striatum and the mesolimbic area of male rat brain. The current findings have implications for the prophylactic and therapeutic potential for MIF-1 in extrapyramidal motor disorders caused by estrogen imbalance in humans.

Animals↗
PubMedDate not supplied

Neuroendocrine concomitants of reproductive aging.

Depletion of ovarian follicles is often thought to be the determining factor in female reproductive aging. However, increasing evidence suggests that neural and neuroendocrine changes play important causative roles in the decline of regular reproductive cycles leading to the menopause. A blunting or suppression in the daily pattern of secretion of several neuroendocrine hormones has been documented in aging laboratory animals and humans. Investigators have designed experiments to test whether these changes reflect multiple unrelated changes in the regulation of each of these hormones, or whether these alterations result from a fundamental change in the time-keeping mechanism that underlie these patterns of hormone secretion. Oscillations that occur approximately every 24 h are a hallmark of most living organisms. These cycles provide the organism with the capability of coordinating events that occur at higher (hourly) and lower (weekly or monthly) frequencies within an individual organism, and with the capability of synchronizing these events with the external environment. In mammals, the hypothalamic suprachiasmatic nucleus is thought to be a master oscillator that regulates most circadian rhythms in mammals. Perturbations in temporal organization occur during aging and influence multiple physiological systems, including reproductive cyclicity in females. Thus, the question for neuroendocrinologists is: Do changes in the cyclic pattern of hormone secretion reflect a change in the master oscillator, and do these changes play a role in female reproductive aging? Data from our laboratory demonstrate that the timing of the preovulatory and steroid-induced luteinizing hormone (LH) surge changes during middle-age in rats.(ABSTRACT TRUNCATED AT 250 WORDS)

Aging↗
PubMedDate not supplied

Capillary electrophoresis determinative and LC-MS confirmatory method for screening selected imidazolinone herbicides from soil.

Residues of imazapyr, imazamox, imazapic, imazethapyr, imazaquin, and imazamethabenz (meta and para) are extracted from soil with 0.5 N sodium hydroxide. The pH is adjusted to 2.0-2.2, and the resulting precipitate is filtered. Compounds are trapped onto a tC18 solid-phase extraction (SPE) cartridge, then eluted from the cartridge and passed through a strong anion exchange (SAX) SPE cartridge onto a benzenesulfonic acid strong cation exchange (SCX) cartridge using ethyl acetate. After eluting the analytes from the SCX cartridge using saturated potassium chloride in methanol, the solution is evaporated and redissolved in 1% formic acid in water. The sample is then desalted using a tC18 SPE cartridge and eluted with methanol. After evaporating the methanol to dryness, the compounds are partitioned from acidic solution (pH 3.5) into methylene chloride. The methylene chloride is evaporated to dryness and the residues are then dissolved in Milli-Q water (Millipore, Bedford, MA, U.S.A.) in preparation for analysis by capillary electrophoresis. Results are calculated by direct comparison of the sample peak heights to the peak heights of bracketing standards. The validated sensitivity of the method (LOQ, limit of quantitation) is 2.0 ppb for each compound. Confirmation for individual residues greater than 2.0 ppb is provided by liquid chromatography-electrospray ionization mass spectrometry (LC-ESMS) of the final extract.

Chromatography, Liquid↗